Archive for the ‘Amplyx Pharmaceuticals’ Category

Amplyx Pharmaceuticals

November 25th, 2015 | Posted in 2015, Amplyx Pharmaceuticals

Amplyx Pharmaceuticals, San Diego, has closed on a $40.5 million Series B financing. Amplyx is currently a tenant of Johnson and Johnson Innovation’s incubator JLABS, and will use the funding to advance the clinical development of APX001, a broad-spectrum antifungal agent to treat life-threatening fungal infections.